Photo from Tom Snow/LinkedIn
May 29, 2024, 12:04
Tom Snow: The FDA accepted for Priority Review Sanofi’s application for investigational therapy in multiple myeloma
Tom Snow, General Manager at US Oncology, Sanofi, shared a post on LinkedIn:
“Today, the FDA accepted for Priority Review Sanofi’s application for our investigational combination regimen in newly diagnosed Multiple Myeloma. This important milestone highlights a key step towards potentially addressing the unmet needs of people living with this blood cancer. Read on to learn more here.”
Source: Tom Snow/LinkedIn
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 23, 2025, 10:18
Mar 23, 2025, 10:18
Mar 23, 2025, 10:11
Mar 23, 2025, 09:57
Mar 23, 2025, 09:57
Mar 23, 2025, 09:50
Mar 23, 2025, 09:45
Mar 23, 2025, 09:43